UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 54

Sortiert nach

Detection and quantification of Aβ−3–40 (APP669‐711) in cerebrospinal fluid

Journal of neurochemistry, 2022-03, Vol.160 (5), p.578-589

2022

Volltextzugriff (PDF)

Blood plasma biomarkers for Alzheimer's disease: Aβ1-42/1-40 vs. AβX-42/X-40

Clinical chemistry and laboratory medicine, 2024-01, Vol.62 (2), p.e56

2024

Volltextzugriff (PDF)

A Combination of Caffeine Supplementation and Enriched Environment in an Alzheimer's Disease Mouse Model

International journal of molecular sciences, 2023-01, Vol.24 (3), p.2155

2023

Volltextzugriff (PDF)

Therapeutic approaches to Alzheimer's disease

Brain (London, England : 1878), 2006-11, Vol.129 (11), p.2840-2855

2006

Volltextzugriff (PDF)

Amino‐terminally elongated Aβ peptides are generated by the secreted metalloprotease ADAMTS4 and deposit in a subset of Alzheimer's disease brains

Neuropathology and applied neurobiology, 2024-06, Vol.50 (3), p.e12991-n/a

2024

Volltextzugriff (PDF)

Is plasma amyloid-β 1–42/1–40 a better biomarker for Alzheimer’s disease than AβX–42/X–40?

Fluids and barriers of the CNS, 2022-12, Vol.19 (1), p.1-96, Article 96

2022

Volltextzugriff (PDF)

Astrocytes and microglia but not neurons preferentially generate N-terminally truncated Aβ peptides

Neurobiology of disease, 2015-01, Vol.73, p.24-35

2015

Volltextzugriff (PDF)

Evaluation of cerebrospinal fluid glycoprotein NMB (GPNMB) as a potential biomarker for Alzheimer's disease

Alzheimer's research & therapy, 2021-05, Vol.13 (1), p.94-94, Article 94

2021

Volltextzugriff (PDF)

High-Fat Diet Induced Isoform Changes of the Parkinson’s Disease Protein DJ‑1

Journal of proteome research, 2014-05, Vol.13 (5), p.2339-2351

2014

Volltextzugriff (PDF)

Solid-Phase Synthesis and Characterization of N-Terminally Elongated Aβ−3-x-Peptides

Chemistry : a European journal, 2016-06, Vol.22 (25), p.8685-8693

2016

Volltextzugriff (PDF)

Brain Region-Specific Differences in Amyloid-β Plaque Composition in 5XFAD Mice

Life (Basel, Switzerland), 2023-04, Vol.13 (4), p.1053

2023

Volltextzugriff (PDF)

Matrix Development for the Detection of Phosphorylated Amyloid‑β Peptides by MALDI-TOF-MS

Journal of the American Society for Mass Spectrometry, 2023-03, Vol.34 (3), p.505-512

2023

Volltextzugriff (PDF)

Structural Design, Solid-Phase Synthesis and Activity of Membrane-Anchored β-Secretase Inhibitors on Aβ Generation from Wild-Type and Swedish-Mutant APP

Chemistry : a European journal, 2010-12, Vol.16 (48), p.14412-14423

2010

Volltextzugriff (PDF)

Assessment of immunoprecipitation with subsequent immunoassays for the blood-based diagnosis of Alzheimer's disease

European archives of psychiatry and clinical neuroscience, 2024-02

2024

Volltextzugriff (PDF)

Urea-based two-dimensional electrophoresis of beta-amyloid peptides in human plasma: Evidence for novel Aβ species

Proteomics (Weinheim), 2007-10, Vol.7 (20), p.3815-3820

2007

Volltextzugriff (PDF)

ERK1/2 protein and mRNA levels in human blood are linked to smoking behavior

Addiction biology, 2012-11, Vol.17 (6), p.1026-1035

2012

Volltextzugriff (PDF)

The Role of Cathepsin B in the Degradation of Aβ and in the Production of Aβ Peptides Starting With Ala2 in Cultured Astrocytes

Frontiers in molecular neuroscience, 2021-01, Vol.13, p.615740-615740

2021

Volltextzugriff (PDF)

Combined CSF tau, p-tau181 and amyloid-β 38/40/42 for diagnosing Alzheimer’s disease

Journal of Neural Transmission, 2009-02, Vol.116 (2), p.203-212

2009

Volltextzugriff (PDF)

Factors Responsible for Plasma β-Amyloid Accumulation in Chronic Kidney Disease

Molecular neurobiology, 2016-07, Vol.53 (5), p.3136-3145

2016

Volltextzugriff (PDF)

Phagocytosis and LPS alter the maturation state of β-amyloid precursor protein and induce different Aβ peptide release signatures in human mononuclear phagocytes

Journal of neuroinflammation, 2010-10, Vol.7 (1), p.59-59, Article 59

2010

Volltextzugriff (PDF)

CSF amyloid-β-peptides in Alzheimer's disease, dementia with Lewy bodies and Parkinson's disease dementia

Brain (London, England : 1878), 2006-05, Vol.129 (5), p.1177-1187

2006

Volltextzugriff (PDF)

Disease tracking markers for Alzheimer's disease at the prodromal (MCI) stage

Journal of Alzheimer's disease, 2011-01, Vol.26 Suppl 3, p.159

2011

Volltextzugriff (PDF)

Association of Plasma β-Amyloid with Cognitive Performance and Decline in Chronic Kidney Disease

Molecular neurobiology, 2017-11, Vol.54 (9), p.7194-7203

2017

Volltextzugriff (PDF)

Improved electrophoretic separation and immunoblotting of beta-amyloid (Aβ) peptides 1-40, 1-42, and 1-43

Electrophoresis, 1997, Vol.18 (3-4), p.527-532

1997

Volltextzugriff (PDF)

Evidence for Elevated Cerebrospinal Fluid ERK1/2 Levels in Alzheimer Dementia

International journal of alzheimer's disease, 2011, Vol.2011, p.739847-9

2011

Volltextzugriff (PDF)

1 – 25 von 54

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(53)
Mit Volltextzugriff
(50)

Publikationsform

Artikel
(54)

Sprache

Englisch
(54)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Detection and quantification of Aβ−3–40 (APP669‐711) in cerebrospinal fluid

Blood plasma biomarkers for Alzheimer's disease: Aβ1-42/1-40 vs. AβX-42/X-40

A Combination of Caffeine Supplementation and Enriched Environment in an Alzheimer's Disease Mouse Model

Therapeutic approaches to Alzheimer's disease

Amino‐terminally elongated Aβ peptides are generated by the secreted metalloprotease ADAMTS4 and deposit in a subset of Alzheimer's disease brains

Is plasma amyloid-β 1–42/1–40 a better biomarker for Alzheimer’s disease than AβX–42/X–40?

Astrocytes and microglia but not neurons preferentially generate N-terminally truncated Aβ peptides

Evaluation of cerebrospinal fluid glycoprotein NMB (GPNMB) as a potential biomarker for Alzheimer's disease

High-Fat Diet Induced Isoform Changes of the Parkinson’s Disease Protein DJ‑1

Solid-Phase Synthesis and Characterization of N-Terminally Elongated Aβ−3-x-Peptides

Brain Region-Specific Differences in Amyloid-β Plaque Composition in 5XFAD Mice

Matrix Development for the Detection of Phosphorylated Amyloid‑β Peptides by MALDI-TOF-MS

Structural Design, Solid-Phase Synthesis and Activity of Membrane-Anchored β-Secretase Inhibitors on Aβ Generation from Wild-Type and Swedish-Mutant APP

Assessment of immunoprecipitation with subsequent immunoassays for the blood-based diagnosis of Alzheimer's disease

Urea-based two-dimensional electrophoresis of beta-amyloid peptides in human plasma: Evidence for novel Aβ species

ERK1/2 protein and mRNA levels in human blood are linked to smoking behavior

The Role of Cathepsin B in the Degradation of Aβ and in the Production of Aβ Peptides Starting With Ala2 in Cultured Astrocytes

Combined CSF tau, p-tau181 and amyloid-β 38/40/42 for diagnosing Alzheimer’s disease

Factors Responsible for Plasma β-Amyloid Accumulation in Chronic Kidney Disease

Phagocytosis and LPS alter the maturation state of β-amyloid precursor protein and induce different Aβ peptide release signatures in human mononuclear phagocytes

CSF amyloid-β-peptides in Alzheimer's disease, dementia with Lewy bodies and Parkinson's disease dementia

Disease tracking markers for Alzheimer's disease at the prodromal (MCI) stage

Association of Plasma β-Amyloid with Cognitive Performance and Decline in Chronic Kidney Disease

Improved electrophoretic separation and immunoblotting of beta-amyloid (Aβ) peptides 1-40, 1-42, and 1-43

Evidence for Elevated Cerebrospinal Fluid ERK1/2 Levels in Alzheimer Dementia

Suchergebnisse filtern